Simone Duarte-Michelan
Sao Carlos, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Identification of a Benzenesulfonylpiperazine Derivative With In Vivo Efficacy Against Visceral Leishmaniasis.
Journal: Chemical biology & drug design
Published: April 10, 2026
Discovery of an efficacious 2-ethyl-4-phenylthiazole derivative against acute Chagas disease via multiparametric hit-to-lead optimization and in vivo efficacy.
Journal: European journal of medicinal chemistry
Published: March 09, 2026
Discovery of Arylpiperazines with Broad-Spectrum Antimicrobial Activity and Favorable Pharmacokinetic Profiles.
Journal: Chemistry & biodiversity
Published: August 24, 2024
Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum.
Journal: Chemical biology & drug design
Published: January 20, 2024
Structure-activity relationships of novel N-imidazoylpiperazines with potent anti-Trypanosoma cruzi activity.
Journal: Future medicinal chemistry
Published: January 09, 2024
Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease.
Journal: European journal of medicinal chemistry
Published: September 25, 2022
Diaminomaleonitrile derivatives as new potential antichagasic compounds: a study of structure-activity relationships.
Journal: Future medicinal chemistry
Published: October 28, 2021
Multiparameter Optimization of Trypanocidal Cruzain Inhibitors With In Vivo Activity and Favorable Pharmacokinetics.
Journal: Frontiers in pharmacology
Published: September 10, 2021
Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents.
Journal: RSC medicinal chemistry
Published: June 04, 2021
2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling.
Journal: PLoS neglected tropical diseases
Published: September 10, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026